Stocks · Health care · Services-Commercial Physical & Biological Research

Incyte

INCY Clue Score71
United States Fiscal year ends December CIK 0000879169 Results filed 29 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Thomas Tray
3 Nov 2026
Principal Accounting Officer
Sold on a plan
610
$118.96
$72.57K
Pablo J Cagnoni
15 Oct 2026
President, Global Head of R&D
Sold after exercise
2,642
$112.71
$297.78K
Pablo J Cagnoni
15 Sep 2026
President, Global Head of R&D
Sold after exercise
13,985
$120.49
$1.69M
Pablo J Cagnoni
15 Sep 2026
President, Global Head of R&D
Sold after exercise
9,233
$120.50
$1.11M
Pablo J Cagnoni
19 Aug 2026
President, Global Head of R&D
Sold on a plan
10,801
$125.56
$1.36M
Pablo J Cagnoni
12 Aug 2026
President, Global Head of R&D
Sold on a plan
10,803
$120.04
$1.30M
Patrick A Mayes
5 Aug 2026
EVP & Chief Scientific Officer
Sold after exercise
2,207
$123.99
$273.65K
Pablo J Cagnoni
5 Aug 2026
President, Global Head of R&D
Sold on a plan
10,640
$122.69
$1.31M
Patrick A Mayes
3 Aug 2026
EVP & Chief Scientific Officer
Sold after exercise
6,055
$120.43
$729.20K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
2,293
$119.41
$273.81K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
326
$121.69
$39.67K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
85
$122.19
$10.39K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
1,642
$119.38
$196.02K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
1,643
$119.51
$196.35K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
2,864
$119.40
$341.96K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
4,695
$119.39
$560.54K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
6,171
$119.43
$737.00K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
2,187
$119.47
$261.28K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
5,332
$119.42
$636.75K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
14,661
$119.46
$1.75M
Pablo J Cagnoni
31 Jul 2026
President, Global Head of R&D
Sold on a plan
15,888
$119.70
$1.90M
Mohamed Khairie Issa
16 Jul 2026
EVP, Head of U.S. Commercial
Sold on a plan
1,093
$115.01
$125.71K
Steven H Stein
16 Jul 2026
CMO & Head of Late-Stage Dev.
Sold on a plan
1,877
$114.73
$215.35K
Steven H Stein
15 Jul 2026
CMO & Head of Late-Stage Dev.
Sold on a plan
28,237
$113.05
$3.19M
Thomas Tray
4 Jun 2026
Principal Accounting Officer
Sold after exercise
2,639
$100.00
$263.90K
Jean Jacques Bienaime
26 May 2026
Director
Exercised, kept
15,000
$84.53
$1.27M
Thomas Tray
26 May 2026
Principal Accounting Officer
Sold on a plan
2,051
$97.35
$199.66K
Paul J Clancy
19 May 2026
Director
Sold after exercise
15,000
$94.93
$1.42M
Baker Bros. Advisors LP
8 May 2026
Director
Exercised, kept indirect
15,000
$84.53
$1.27M
Baker Bros. Advisors LP
8 May 2026
Director
Exercised, kept indirect
15,000
$84.53
$1.27M
Pablo J Cagnoni
17 Apr 2026
President, Global Head of R&D
Sold after exercise
18,667
$96.50
$1.80M
Pablo J Cagnoni
17 Mar 2026
President, R&D
Sold after exercise
18,667
$94.24
$1.76M
Pablo J Cagnoni
19 Feb 2026
President, R&D
Sold after exercise
18,668
$100.91
$1.88M
Mohamed Khairie Issa
7 Jan 2026
EVP, Head of US Oncology
Sold on a plan
10,856
$109.07
$1.18M
Steven H Stein
5 Jan 2026
EVP & Chief Medical Officer
Sold on a plan
15,634
$101.70
$1.59M
Thomas Tray
19 Dec 2025
Principal Accounting Officer
Sold after exercise
2,774
$100.00
$277.40K
Thomas Tray
18 Dec 2025
Principal Accounting Officer
Sold on a plan
600
$98.25
$58.95K
Michael James Morrissey
17 Dec 2025
EVP, Head of Tech. Operations
Sold on a plan
4,323
$97.26
$420.45K
Michael James Morrissey
16 Dec 2025
EVP, Head of Tech. Operations
Sold on a plan
53,175
$97.29
$5.17M
Michael James Morrissey
16 Dec 2025
EVP, Head of Tech. Operations
Sold on a plan
833
$97.42
$81.15K
Patrick A Mayes
11 Dec 2025
EVP & Chief Scientific Officer
Sold on a plan
255
$94.94
$24.21K
Patrick A Mayes
10 Dec 2025
EVP & Chief Scientific Officer
Sold on a plan
5,553
$95.58
$530.76K
Steven H Stein
2 Dec 2025
EVP & Chief Medical Officer
Sold on a plan
20,105
$102.51
$2.06M
Steven H Stein
1 Dec 2025
EVP & Chief Medical Officer
Sold on a plan
2,559
$102.96
$263.47K
Thomas Tray
24 Nov 2025
Principal Accounting Officer
Sold on a plan
600
$103.00
$61.80K
Thomas Tray
21 Nov 2025
Principal Accounting Officer
Sold on a plan
169
$102.00
$17.24K
Sheila A. Denton
17 Nov 2025
EVP & General Counsel
Sold after exercise
278
$104.36
$29.01K
Herve Hoppenot
10 Nov 2025
Director
Sold on a plan
187,500
$105.46
$19.77M
Steven H Stein
5 Nov 2025
EVP & Chief Medical Officer
Sold after exercise
5,233
$102.20
$534.81K
Sheila A. Denton
4 Nov 2025
EVP & General Counsel
Sold after exercise
598
$101.36
$60.61K
Lee Heeson
3 Nov 2025
EVP, Head of Incyte Intl
Sold on a plan
3,074
$94.02
$289.02K
Sheila A. Denton
15 Oct 2025
EVP & General Counsel
Sold after exercise
277
$85.13
$23.58K
Sheila A. Denton
3 Oct 2025
EVP & General Counsel
Sold on a plan
3,501
$85.54
$299.48K
Sheila A. Denton
2 Oct 2025
EVP & General Counsel
Sold after exercise
599
$87.65
$52.50K
Sheila A. Denton
16 Sep 2025
EVP & General Counsel
Sold after exercise
278
$83.15
$23.12K
Sheila A. Denton
2 Sep 2025
EVP & General Counsel
Sold after exercise
598
$84.97
$50.81K
Sheila A. Denton
15 Aug 2025
EVP & General Counsel
Sold after exercise
277
$86.81
$24.05K
Sheila A. Denton
4 Aug 2025
EVP & General Counsel
Sold after exercise
598
$75.77
$45.31K
Steven H Stein
21 Jul 2025
EVP & Chief Medical Officer
Sold on a plan
3,706
$67.94
$251.79K
Sheila A. Denton
16 Jul 2025
EVP & General Counsel
Sold on a plan
785
$68.36
$53.66K
Vijay K Iyengar
16 Jul 2025
EVP, Gmapps
Sold on a plan
983
$68.36
$67.20K
Barry P Flannelly
16 Jul 2025
EVP & General Manager US
Sold on a plan
1,340
$68.36
$91.60K
Barry P Flannelly
15 Jul 2025
EVP & General Manager US
Sold on a plan
1,192
$69.86
$83.27K
Vijay K Iyengar
15 Jul 2025
EVP, Gmapps
Sold on a plan
1,177
$69.86
$82.23K
Sheila A. Denton
15 Jul 2025
EVP & General Counsel
Sold after exercise
3,330
$69.86
$232.63K
Steven H Stein
14 Jul 2025
EVP & Chief Medical Officer
Sold on a plan
14,952
$68.47
$1.02M
Vijay K Iyengar
3 Jul 2025
EVP, Gmapps
Sold on a plan
5,935
$68.15
$404.47K
Vijay K Iyengar
3 Jul 2025
EVP, Gmapps
Sold on a plan
2,682
$68.16
$182.81K
Barry P Flannelly
3 Jul 2025
EVP & General Manager US
Sold on a plan
10,903
$68.15
$743.04K
Sheila A. Denton
2 Jul 2025
EVP & General Counsel
Sold after exercise
599
$68.61
$41.10K
Sheila A. Denton
3 Jun 2025
EVP & General Counsel
Sold after exercise
1,795
$68.00
$122.06K
Thomas Tray
2 Jun 2025
Principal Accounting Officer
Sold on a plan
651
$64.88
$42.24K
Thomas Tray
30 May 2025
Principal Accounting Officer
Sold on a plan
963
$65.71
$63.28K
Barry P Flannelly
14 Mar 2025
EVP & General Manager US
Sold on a plan
19,147
$67.68
$1.30M
Barry P Flannelly
14 Mar 2025
EVP & General Manager US
Sold on a plan
199
$67.88
$13.51K
Barry P Flannelly
14 Mar 2025
EVP & General Manager US
Sold on a plan
461
$67.85
$31.28K
Sheila A. Denton
4 Mar 2025
EVP & General Counsel
Sold after exercise
599
$69.99
$41.92K
Sheila A. Denton
26 Feb 2025
EVP & General Counsel
Sold after exercise
4,495
$74.08
$332.99K
Sheila A. Denton
26 Feb 2025
EVP & General Counsel
Sold after exercise
9,574
$74.07
$709.15K
Steven H Stein
21 Jan 2025
EVP & Chief Medical Officer
Sold on a plan
12,352
$72.69
$897.87K
Thomas Tray
16 Dec 2024
Principal Accounting Officer
Sold on a plan
650
$69.31
$45.05K
Thomas Tray
13 Dec 2024
Principal Accounting Officer
Sold on a plan
650
$70.64
$45.92K
Vijay K Iyengar
29 Nov 2024
EVP, Gmapps
Sold on a plan
5,683
$75.37
$428.33K
Vijay K Iyengar
29 Nov 2024
EVP, Gmapps
Sold on a plan
360
$75.60
$27.22K
Barry P Flannelly
6 Nov 2024
EVP & General Manager US
Sold after exercise
2,256
$78.21
$176.44K
Barry P Flannelly
6 Nov 2024
EVP & General Manager US
Sold after exercise
1,424
$82.00
$116.77K
Thomas Tray
13 Sep 2024
Principal Accounting Officer
Sold on a plan
382
$63.37
$24.21K
Jonathan Elliott Dickinson
12 Sep 2024
EVP, General Manager, Europe
Sold on a plan
7,333
$62.37
$457.36K
Jonathan Elliott Dickinson
12 Sep 2024
EVP, General Manager, Europe
Sold on a plan
1,117
$62.30
$69.59K
Thomas Tray
12 Sep 2024
Principal Accounting Officer
Sold on a plan
572
$62.94
$36.00K
Steven H Stein
12 Aug 2024
EVP & Chief Medical Officer
Sold on a plan
11,608
$60.63
$703.79K
Vijay K Iyengar
25 Jul 2024
EVP, Gmapps
Sold on a plan
15,571
$70.00
$1.09M
Barry P Flannelly
16 Jul 2024
EVP & General Manager US
Sold on a plan
1,306
$64.19
$83.83K
Barry P Flannelly
9 Jul 2024
EVP & General Manager US
Sold on a plan
8,148
$60.00
$488.88K
Barry P Flannelly
12 Jun 2024
EVP & General Manager US
Sold on a plan
19,164
$60.00
$1.15M
Thomas Tray
6 Jun 2024
Principal Accounting Officer
Sold on a plan
1,093
$58.91
$64.39K
Baker Bros. Advisors LP
7 May 2024
Director
Exercised, kept indirect
15,000
$49.01
$735.15K
Baker Bros. Advisors LP
7 May 2024
Director
Exercised, kept indirect
15,000
$49.01
$735.15K
Steven H Stein
3 Jan 2024
EVP & Chief Medical Officer
Sold on a plan
7,365
$65.51
$482.48K
Vijay K Iyengar
2 Jan 2024
EVP, Gmapps
Sold on a plan
657
$65.00
$42.71K
Thomas Tray
13 Dec 2023
Principal Accounting Officer
Sold on a plan
1,067
$62.37
$66.55K
Thomas Tray
12 Dec 2023
Principal Accounting Officer
Sold on a plan
210
$57.36
$12.05K
Paula J Swain
1 Sep 2023
EVP, Human Resources
Sell
8,449
$65.13
$550.28K
Steven H Stein
1 Aug 2023
EVP & Chief Medical Officer
Sold on a plan
21,511
$63.28
$1.36M
Baker Bros. Advisors LP
13 Mar 2023
Director
Exercised, kept indirect
20,000
$22.74
$454.80K
Baker Bros. Advisors LP
13 Mar 2023
Director
Exercised, kept indirect
20,000
$22.74
$454.80K
Dashyant Dhanak
16 Feb 2023
EVP & Chief Scientific Officer
Exercised, kept
3,693
$65.42
$241.60K
Maria E Pasquale
31 Jan 2023
EVP & General Counsel
Sold after exercise
802
$84.06
$67.42K
Maria E Pasquale
30 Jan 2023
EVP & General Counsel
Sold after exercise
4,842
$84.73
$410.26K
Maria E Pasquale
30 Jan 2023
EVP & General Counsel
Sold after exercise
5,644
$85.07
$480.14K
Maria E Pasquale
30 Jan 2023
EVP & General Counsel
Sold after exercise
14,374
$84.73
$1.22M
Maria E Pasquale
30 Jan 2023
EVP & General Counsel
Sold after exercise
11,861
$84.70
$1.00M
Maria E Pasquale
30 Jan 2023
EVP & General Counsel
Sold after exercise
10,438
$84.70
$884.10K
Maria E Pasquale
30 Jan 2023
EVP & General Counsel
Sold after exercise
12,865
$84.69
$1.09M
Dashyant Dhanak
26 Jan 2023
EVP & Chief Scientific Officer
Sell
2,419
$85.00
$205.62K
Vijay K Iyengar
26 Jan 2023
EVP, Gmapps
Sold after exercise
7,000
$85.00
$595.00K
Steven H Stein
4 Jan 2023
EVP & Chief Medical Officer
Sell
28,399
$79.78
$2.27M
Vijay K Iyengar
23 Dec 2022
EVP, Gmapps
Sold after exercise
1,654
$80.79
$133.63K
Vijay K Iyengar
23 Dec 2022
EVP, Gmapps
Sold after exercise
804
$80.77
$64.94K
Vijay K Iyengar
23 Dec 2022
EVP, Gmapps
Sold after exercise
7,000
$80.80
$565.60K
Vijay K Iyengar
23 Dec 2022
EVP, Gmapps
Sold after exercise
7,866
$80.80
$635.57K
Thomas Tray
19 Dec 2022
Principal Accounting Officer
Sell
1,223
$82.16
$100.48K
Thomas Tray
22 Jul 2022
Principal Accounting Officer
Sell
1,564
$83.13
$130.02K
Barry P Flannelly
7 Jul 2022
EVP & General Manager US
Sell
2,873
$79.38
$228.06K
Vijay K Iyengar
7 Jul 2022
EVP, Gmapps
Sell
5,787
$79.38
$459.37K
Barry P Flannelly
8 Apr 2022
EVP & General Manager US
Sold after exercise
1,248
$82.96
$103.53K
Barry P Flannelly
8 Apr 2022
EVP & General Manager US
Sold after exercise
881
$82.96
$73.09K
Barry P Flannelly
8 Apr 2022
EVP & General Manager US
Sold after exercise
21,348
$84.00
$1.79M
Barry P Flannelly
8 Apr 2022
EVP & General Manager US
Sold after exercise
20,516
$83.01
$1.70M
Baker Bros. Advisors LP
10 Mar 2022
Director
Buy indirect
175,795
$73.31
$12.89M
Baker Bros. Advisors LP
10 Mar 2022
Director
Buy indirect
14,490
$73.31
$1.06M
Baker Bros. Advisors LP
10 Mar 2022
Director
Buy indirect
1,017
$71.95
$73.18K
Baker Bros. Advisors LP
10 Mar 2022
Director
Buy indirect
84
$71.95
$6.04K
Baker Bros. Advisors LP
10 Mar 2022
Director
Buy indirect
25,107
$71.90
$1.81M
Baker Bros. Advisors LP
10 Mar 2022
Director
Buy indirect
2,070
$71.90
$148.83K
Baker Bros. Advisors LP
9 Mar 2022
Director
Buy indirect
65,147
$71.72
$4.67M
Baker Bros. Advisors LP
9 Mar 2022
Director
Buy indirect
5,370
$71.72
$385.14K
Baker Bros. Advisors LP
8 Mar 2022
Director
Buy indirect
92,385
$70.68
$6.53M
Baker Bros. Advisors LP
8 Mar 2022
Director
Buy indirect
7,615
$70.68
$538.19K
Baker Bros. Advisors LP
8 Mar 2022
Director
Exercised, kept indirect
20,000
$22.05
$441.00K
Baker Bros. Advisors LP
8 Mar 2022
Director
Exercised, kept indirect
20,000
$22.05
$441.00K
Baker Bros. Advisors LP
22 Feb 2022
Director
Buy indirect
92,234
$68.07
$6.28M
Baker Bros. Advisors LP
22 Feb 2022
Director
Buy indirect
7,566
$68.07
$515.03K
Baker Bros. Advisors LP
18 Feb 2022
Director
Buy indirect
22,178
$68.43
$1.52M
Baker Bros. Advisors LP
18 Feb 2022
Director
Buy indirect
1,827
$68.43
$125.02K
Baker Bros. Advisors LP
18 Feb 2022
Director
Buy indirect
100,731
$68.37
$6.89M
Baker Bros. Advisors LP
18 Feb 2022
Director
Buy indirect
8,296
$68.37
$567.17K
Baker Bros. Advisors LP
17 Feb 2022
Director
Buy indirect
285,672
$67.74
$19.35M
Baker Bros. Advisors LP
17 Feb 2022
Director
Buy indirect
7,300
$67.40
$491.98K
Baker Bros. Advisors LP
14 Feb 2022
Director
Buy indirect
182,326
$66.04
$12.04M
Baker Bros. Advisors LP
14 Feb 2022
Director
Buy indirect
320,526
$66.02
$21.16M
Baker Bros. Advisors LP
11 Feb 2022
Director
Buy indirect
10,985
$66.95
$735.43K
Baker Bros. Advisors LP
11 Feb 2022
Director
Buy indirect
265,522
$66.81
$17.74M
Baker Bros. Advisors LP
10 Feb 2022
Director
Buy indirect
772,751
$67.54
$52.19M
Baker Bros. Advisors LP
10 Feb 2022
Director
Buy indirect
6,100
$67.20
$409.90K
Baker Bros. Advisors LP
10 Feb 2022
Director
Buy indirect
40,164
$66.57
$2.67M
Jonathan Elliott Dickinson
31 Jan 2022
EVP, General Manager, Europe
Sell
7,375
$74.19
$547.15K
Paula J Swain
7 Jan 2022
EVP, Human Resources
Sold after exercise
10,870
$73.31
$796.88K
Paula J Swain
4 Jan 2022
EVP, Human Resources
Sold after exercise
9,319
$73.46
$684.57K
Paul Trower
3 Jan 2022
Principal Accounting Officer
Sold after exercise
1,396
$73.31
$102.34K
Paul Trower
3 Jan 2022
Principal Accounting Officer
Sold after exercise
6,818
$73.31
$499.83K
Wendy L Dixon
23 Dec 2021
Director
Sold after exercise
20,000
$22.05
left out
Baker Bros. Advisors LP
17 Dec 2021
Director
Buy indirect
193,997
$72.91
$14.14M
Baker Bros. Advisors LP
17 Dec 2021
Director
Buy indirect
881,875
$72.77
$64.18M
Baker Bros. Advisors LP
16 Dec 2021
Director
Buy indirect
29,703
$72.00
$2.14M
Baker Bros. Advisors LP
16 Dec 2021
Director
Buy indirect
139,612
$71.96
$10.05M
Baker Bros. Advisors LP
15 Dec 2021
Director
Buy indirect
288,368
$71.91
$20.74M
Baker Bros. Advisors LP
15 Dec 2021
Director
Buy indirect
5,382
$71.03
$382.30K
Baker Bros. Advisors LP
15 Dec 2021
Director
Buy indirect
9,893
$70.24
$694.84K
Baker Bros. Advisors LP
15 Dec 2021
Director
Buy indirect
36,476
$69.63
$2.54M
Baker Bros. Advisors LP
15 Dec 2021
Director
Buy indirect
9,352
$68.52
$640.84K
Baker Bros. Advisors LP
15 Dec 2021
Director
Buy indirect
861
$67.90
$58.46K
Dashyant Dhanak
1 Oct 2021
EVP & Chief Scientific Officer
Sell
389
$68.67
$26.71K
Maria E Pasquale
24 Sep 2021
EVP & General Counsel
Exercised, kept
382
$65.36
$24.97K
Paula J Swain
20 Sep 2021
EVP, Human Resources
Exercised, kept
1,356
$73.21
$99.27K
Dashyant Dhanak
1 Sep 2021
EVP & Chief Scientific Officer
Sell
388
$76.71
$29.76K
Dashyant Dhanak
2 Aug 2021
EVP & Chief Scientific Officer
Sell
389
$77.49
$30.14K
Vijay K Iyengar
29 Jul 2021
EVP GPS, BD, & Licensing
Sell
4,911
$78.29
$384.48K
Dashyant Dhanak
1 Jul 2021
EVP & Chief Scientific Officer
Sell
396
$84.09
$33.30K
Yao Wenqing
29 Jun 2021
EVP, Head of Discovery Chem
Sell
27,194
$85.37
$2.32M
Maria E Pasquale
18 Jun 2021
EVP & General Counsel
Exercised, kept
255
$65.36
$16.67K
Dashyant Dhanak
10 Jun 2021
EVP & Chief Scientific Officer
Sold after exercise
3,845
$87.00
$334.52K
Dashyant Dhanak
1 Jun 2021
EVP & Chief Scientific Officer
Sell
395
$84.13
$33.23K
Baker Bros. Advisors LP
14 May 2021
Director
Exercised, kept indirect
20,000
$18.97
$379.40K
Baker Bros. Advisors LP
14 May 2021
Director
Exercised, kept indirect
20,000
$18.97
$379.40K
Dashyant Dhanak
3 May 2021
EVP & Chief Scientific Officer
Sell
396
$85.40
$33.82K
Maria E Pasquale
23 Apr 2021
EVP & General Counsel
Exercised, kept
127
$65.36
$8.30K
Dashyant Dhanak
1 Apr 2021
EVP & Chief Scientific Officer
Sell
396
$81.57
$32.30K
Michael James Morrissey
29 Mar 2021
EVP, Head of Tech. Operations
Sell
20,000
$81.08
$1.62M
Maria E Pasquale
12 Mar 2021
EVP & General Counsel
Exercised, kept
128
$65.36
$8.37K
Dashyant Dhanak
1 Mar 2021
EVP & Chief Scientific Officer
Sell
395
$79.73
$31.49K
Herve Hoppenot
23 Feb 2021
Chairman / CEO
Buy
12,925
$77.37
$1.00M
Maria E Pasquale
16 Feb 2021
EVP & General Counsel
Exercised, kept
127
$65.36
$8.30K
Dashyant Dhanak
1 Feb 2021
EVP & Chief Scientific Officer
Sold after exercise
395
$90.00
$35.55K
Dashyant Dhanak
1 Feb 2021
EVP & Chief Scientific Officer
Sold after exercise
961
$90.00
$86.49K
Barry P Flannelly
25 Jan 2021
EVP & General Manager US
Sell
2,744
$100.00
$274.40K
Vijay K Iyengar
25 Jan 2021
EVP GPS, BD, & Licensing
Sold after exercise
1,000
$99.00
$99.00K
Vijay K Iyengar
25 Jan 2021
EVP GPS, BD, & Licensing
Sold after exercise
4,116
$99.00
$407.48K
Steven H Stein
25 Jan 2021
EVP & Chief Medical Officer
Sold after exercise
3,795
$100.00
$379.50K
Yao Wenqing
25 Jan 2021
EVP, Head of Discovery Chem
Sold after exercise
19,986
$100.00
$2.00M
Yao Wenqing
25 Jan 2021
EVP, Head of Discovery Chem
Sold after exercise
1,559
$100.00
$155.90K
Maria E Pasquale
11 Jan 2021
EVP & General Counsel
Exercised, kept
127
$65.36
$8.30K
Maria E Pasquale
11 Dec 2020
EVP & General Counsel
Exercised, kept
128
$65.36
$8.37K
Maria E Pasquale
12 Nov 2020
EVP & General Counsel
Exercised, kept
127
$65.36
$8.30K
Jean Jacques Bienaime
10 Nov 2020
Director
Sell
798
$83.00
$66.23K
Dashyant Dhanak
6 Nov 2020
EVP & Chief Scientific Officer
Sold after exercise
961
$85.17
$81.85K
Barry P Flannelly
2 Nov 2020
EVP & General Manager US
Sold after exercise
20,000
$86.60
$1.73M
Maria E Pasquale
12 Oct 2020
EVP & General Counsel
Exercised, kept
128
$65.36
$8.37K
Maria E Pasquale
9 Oct 2020
EVP & General Counsel
Sold after exercise
1,423
$95.00
$135.19K
Dashyant Dhanak
6 Oct 2020
EVP & Chief Scientific Officer
Sold after exercise
961
$91.97
$88.38K
Maria E Pasquale
11 Sep 2020
EVP & General Counsel
Exercised, kept
127
$65.36
$8.30K
Maria E Pasquale
10 Sep 2020
EVP & General Counsel
Sold after exercise
2,193
$90.83
$199.19K
Dashyant Dhanak
8 Sep 2020
EVP & Chief Scientific Officer
Sold after exercise
961
$88.94
$85.47K
Wendy L Dixon
27 Aug 2020
Director
Sold after exercise
20,000
$94.51
$1.89M
Maria E Pasquale
10 Aug 2020
EVP & General Counsel
Exercised, kept
128
$65.36
$8.37K
Dashyant Dhanak
6 Aug 2020
EVP & Chief Scientific Officer
Sold after exercise
961
$97.80
$93.99K
Steven H Stein
16 Jul 2020
EVP & Chief Medical Officer
Sell
766
$103.83
$79.53K
Dashyant Dhanak
13 Jul 2020
EVP & Chief Scientific Officer
Exercised, kept
2,419
$65.42
$158.25K
Maria E Pasquale
10 Jul 2020
EVP & General Counsel
Exercised, kept
127
$65.36
$8.30K
Steven H Stein
8 Jul 2020
EVP & Chief Medical Officer
Sell
610
$108.56
$66.22K
Vijay K Iyengar
8 Jul 2020
EVP GPS, BD, & Licensing
Sell
475
$108.56
$51.57K
Herve Hoppenot
7 Jul 2020
Chairman / CEO
Sold after exercise
88,406
$110.00
$9.72M
Herve Hoppenot
7 Jul 2020
Chairman / CEO
Sold after exercise
1,365
$110.00
$150.15K
Steven H Stein
7 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
3,283
$107.99
$354.53K
Steven H Stein
7 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
7,495
$110.04
$824.75K
Steven H Stein
7 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
3,381
$110.04
$372.05K
Vijay K Iyengar
7 Jul 2020
EVP GPS, BD, & Licensing
Sell
3,120
$107.98
$336.90K
Dashyant Dhanak
6 Jul 2020
EVP & Chief Scientific Officer
Sold after exercise
961
$106.58
$102.42K
Steven H Stein
6 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
10,437
$107.31
$1.12M
Steven H Stein
6 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
10,437
$107.31
$1.12M
Steven H Stein
6 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
12,132
$107.31
$1.30M
Steven H Stein
6 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
596
$107.31
$63.96K
Steven H Stein
6 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
2,522
$106.40
$268.34K
Yao Wenqing
6 Jul 2020
EVP, Head of Discovery Chem
Sold after exercise
15,648
$107.32
$1.68M
Yao Wenqing
6 Jul 2020
EVP, Head of Discovery Chem
Sold after exercise
905
$107.32
$97.12K
Herve Hoppenot
26 Jun 2020
Chairman / CEO
Sold after exercise
119,501
$102.91
$12.30M
Herve Hoppenot
26 Jun 2020
Chairman / CEO
Sold after exercise
4,647
$102.91
$478.22K
Barry P Flannelly
23 Jun 2020
EVP & General Manager US
Sold after exercise
400
$110.00
$44.00K
Paul Trower
23 Jun 2020
Principal Accounting Officer
Sold after exercise
6,943
$110.00
$763.73K
Jonathan Elliott Dickinson
22 Jun 2020
EVP, General Manager, Europe
Sell
9,000
$105.31
$947.79K
Barry P Flannelly
19 Jun 2020
EVP & General Manager US
Sold after exercise
7,181
$105.00
$754.01K
Vijay K Iyengar
19 Jun 2020
EVP GPS, BD, & Licensing
Sold after exercise
7,866
$105.00
$825.93K
Maria E Pasquale
19 Jun 2020
EVP & General Counsel
Sold after exercise
1,423
$100.00
$142.30K
Maria E Pasquale
12 Jun 2020
EVP & General Counsel
Exercised, kept
127
$65.36
$8.30K
Maria E Pasquale
10 Jun 2020
EVP & General Counsel
Sold after exercise
2,192
$94.19
$206.46K
Maria E Pasquale
10 Jun 2020
EVP & General Counsel
Sold after exercise
1,423
$95.00
$135.19K
Dashyant Dhanak
8 Jun 2020
EVP & Chief Scientific Officer
Sold after exercise
961
$91.87
$88.29K
Baker Bros. Advisors LP
28 May 2020
Director
Buy indirect
1
$102.55
$102.55
Baker Bros. Advisors LP
28 May 2020
Director
Buy indirect
1
$102.55
$102.55
Maria E Pasquale
11 May 2020
EVP & General Counsel
Exercised, kept
128
$65.36
$8.37K
Showing 250 of 401 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 919
Amendments (4/A) skipped 3
Filings about a different issuer 4
Unreadable filings 0
Joint filings 64
Sales on a Rule 10b5-1 plan 59
Sales straight out of an exercise 194
Sales at will 48
Transactions with no price 1
Shares from compensation/vesting 24,644,751
Sales filed before the plan box existed 47
History held since 13 Oct 2006